VEGFA and neoplasm: One study found that mice treated with a colony stimulating factor inhibitor AC708, an anti-VEGF antibody, and paclitaxel had 83% lower tumor burden at the end of the study than mice who were treated with these drugs alone, suggesting that prevention of macrophage differentiation and proliferation may inhibit development of resistance to these drugs [190].